Shanghai Junshi Biosciences Co., Ltd. (01877) said it intends to enter into a licence agreement with Anwita Biosciences, Inc. (Anwita).
Anwita will grant the company an exclusive licence of Anti-HSA-IL-2N series products and related ANWITA technology and intellectual property rights or an exclusive licence used in conjunction with the proprietary products of the company as agreed under the agreement in the licensed territory (including mainland China, HKSAR, Macau SAR and Taiwan region).
30/09/2020 15:16
Junshi Bio (01877) intends to sign licence agreement
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
